Literature DB >> 12434138

Diet modulates the toxicity of cancer chemotherapy in rats.

Richard F Branda1, Zhuan Chen, Elice M Brooks, Shelly J Naud, Thomas D Trainer, John J McCormack.   

Abstract

The effects of diet and folate status on cyclophosphamide or 5-fluorouracil toxicity were studied in Fischer 344 rats maintained on either a cereal-based diet or a purified diet (AIN-93G). The rats fed the purified diet were divided into 3 groups: folate deficient (no dietary folic acid), folate replete (2 mg folic acid/kg diet), and high folate (2 mg folic acid/kg diet plus 50 mg/kg body weight folic acid intraperitoneally daily). The LD50 for cyclophosphamide was significantly higher for the cereal diet than for the purified diets, but there was no difference among the purified diets. Deaths were predicted by dose, diet, white blood cell count, and BUN on Day 4 after treatment. In the saline-treated rats fed the purified diet, hepatic total glutathione levels increased in the following order: folate deficient < folate replete < high folate. There was no significant difference in aldehyde dehydogenase activities or of microsomal P450 levels in livers from rats on the different diets. In the rats treated with 5-fluorouracil, the high folate rats developed more severe anemia, azotemia, and leukopenia than the other groups. Weight, white blood cell count, hematocrit, and BUN were important predictors of death. The kidneys from rats fed the cereal-based diet were histologically normal, but rats ingesting the purified diet had increasing renal pathology that correlated with folate intake. These results indicate that diet has an important influence on the toxicity of cyclophosphamide and 5-fluorouracil and that folate status modulates hepatic glutathione levels, which is a major cellular defense against oxidant and alkylating agent damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434138     DOI: 10.1067/mlc.2002.128648

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  7 in total

1.  Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal Cancer.

Authors:  Stephen L Chan; Anthony W H Chan; Frankie Mo; Brigette B Y Ma; Kenneth C W Wong; Daisy Lam; Florence S T Mok; Anthony T C Chan; Tony Mok; K C Allen Chan
Journal:  Oncologist       Date:  2018-05-25

2.  Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats.

Authors:  Jeffrey M Long; Garrick D Lee; Bennett Kelley-Bell; Edward L Spangler; Evelyn J Perez; Dan L Longo; Rafael de Cabo; Sige Zou; Peter R Rapp
Journal:  Pharmacol Biochem Behav       Date:  2011-08-22       Impact factor: 3.533

3.  Antiglycation effects of carnosine and other compounds on the long-term survival of Escherichia coli.

Authors:  Evan D Pepper; Michael J Farrell; Gary Nord; Steven E Finkel
Journal:  Appl Environ Microbiol       Date:  2010-10-15       Impact factor: 4.792

4.  Evaluation of the progression and treatment of experimental periodontitis in rats subjected to chemotherapy with 5-fluorouracil.

Authors:  Valdir Gouveia Garcia; Vivian Cristina Noronha Novaes; Juliano Milanezi de Almeida; Mariéllen Longo; Edilson Ervolino; Suely Regina Mogami Bomfim; Leticia Helena Theodoro
Journal:  Support Care Cancer       Date:  2014-12-18       Impact factor: 3.603

Review 5.  Capecitabine: have we got the dose right?

Authors:  Rachel Midgley; David J Kerr
Journal:  Nat Clin Pract Oncol       Date:  2008-10-21

6.  The effects of cyclophosphamide on hippocampal cell proliferation and spatial working memory in rat.

Authors:  Laura Lyons; Maha Elbeltagy; Geoffrey Bennett; Peter Wigmore
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

7.  An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity.

Authors:  A R Minchom; K Saksornchai; J Bhosle; R Gunapala; M Puglisi; S K Lu; K Nimako; J Coward; K C Yu; P Bordi; S Popat; M E R O'Brien
Journal:  BMJ Open Respir Res       Date:  2014-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.